Lv7
4035 积分 2021-06-09 加入
Abstract 3326: PMR-116, a second generation RNA Polymerase I inhibitor
13小时前
求助中
Development of a Buchwald–Hartwig Amination for an Accelerated Library Synthesis of Cereblon Binders
17天前
已完结
Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation
17天前
已完结
GPCR drug discovery: new agents, targets and indications
18天前
已完结
Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective
25天前
已完结
Plasma Protein Binding as an Optimizable Parameter for In Vivo Efficacy
1个月前
已完结
Linker-free PROTACs efficiently induce the degradation of oncoproteins
1个月前
已完结
Discovery of the First Clinical Protein Degrader for the Treatment of Autoimmune Indications: Orally Bioavailable and Selective IRAK4 Degrader KT-474
1个月前
已完结
Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases
1个月前
已完结
Accelerating Medicinal Chemistry: A C(sp3)-rich Fragment Toolbox for Redox-Neutral Cross-Coupling
1个月前
已完结
皖公网安备34019202002308
